Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127888021 | 12788802 | 1 | I | 20160915 | 20160928 | 20160928 | EXP | DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-124579 | RANBAXY | 0.00 | C | Y | 0.00000 | 20160928 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127888021 | 12788802 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 2 CYCLES OF N5 | 0 | ||||||||||
| 127888021 | 12788802 | 2 | PS | Doxorubicin | DOXORUBICIN | 1 | Unknown | 2 CYCLES OF N6 | 91418 | ||||||||||
| 127888021 | 12788802 | 3 | SS | Vincristine | VINCRISTINE | 1 | Unknown | 2 CYCLES OF N6 | 0 | ||||||||||
| 127888021 | 12788802 | 4 | SS | TOPOTECAN | TOPOTECANTOPOTECAN HYDROCHLORIDE | 1 | Unknown | 2 CYCLES OF N8 | 0 | ||||||||||
| 127888021 | 12788802 | 5 | SS | TOPOTECAN | TOPOTECANTOPOTECAN HYDROCHLORIDE | 1 | Unknown | 1 CYCLE OF TE | 0 | ||||||||||
| 127888021 | 12788802 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 2 CYCLES OF N5 | 0 | ||||||||||
| 127888021 | 12788802 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 2 CYCLES OF N5 | 0 | ||||||||||
| 127888021 | 12788802 | 8 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 1 CYCLES OF TE | 0 | ||||||||||
| 127888021 | 12788802 | 9 | SS | Vindesine | VINDESINE | 1 | Unknown | 2 CYCLES OF N5 | 0 | ||||||||||
| 127888021 | 12788802 | 10 | SS | DACARBACIN | DACARBAZINE | 1 | Unknown | 2 CYCLES OF N6 | 0 | ||||||||||
| 127888021 | 12788802 | 11 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | 2 CYCLES OF N6 | 0 | ||||||||||
| 127888021 | 12788802 | 12 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 2 CYCLES OF N8 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127888021 | 12788802 | 1 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 2 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 3 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 4 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 6 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 9 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 10 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 11 | Ganglioneuroblastoma |
| 127888021 | 12788802 | 12 | Ganglioneuroblastoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127888021 | 12788802 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127888021 | 12788802 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |